Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

24432 ARTÍCULOS , VIENDO DEL 23071 AL 23085

Genetics and Epigenetics of Alzheimer's Disease: Understanding Pathogenesis and Exploring Therapeutic Potential

Tiwari P, Dwivedi R, Kaushik M, Tripathi M, Dada R.

J Mol Neurosci. 2025 May 30;75(2):72. doi: 10.1007/s12031-025-02363-2.

Insulin resistance: fueling oxidative stress and neurodegeneration

Chamorro LB, Zulli B, Barone E.

J Neural Transm (Vienna). 2025 Oct;132(10):1567-1586. doi: 10.1007/s00702-025-02956-6. Epub 2025 May 31.

The role of mitochondrial dysfunction in the pathogenesis of Alzheimer's disease and future strategies for targeted therapy

Li X, Wu Z, Si X, Li J, Wu G, Wang M.

Eur J Med Res. 2025 May 31;30(1):434. doi: 10.1186/s40001-025-02699-w.

Targeting Alzheimer's disease pathology: influence of nano-based drug delivery systems loaded with a combination of herbal and synthetic drugs

Mumtaz, Unnithan D, Bano A, Chauhan APS, Ali J, Khan MA.

Expert Opin Drug Deliv. 2025 Aug;22(8):1155-1170. doi: 10.1080/17425247.2025.2513440. Epub 2025 Jun 18.

Large language models for Alzheimer's disease drug discovery

Alkam T, Tarshizi E, Van Benschoten AH.

J Alzheimers Dis. 2025 Aug;106(3):799-822. doi: 10.1177/13872877251346890. Epub 2025 Jun 2.

CD2AP at the junction of nephropathy and Alzheimer's disease

Vandal M, Janmaleki M, Rea I, Gunn C, Hirai S, Biernaskie J, Chun J, Gordon G, Shaw A, Sanati-Nezhad A, Pfeffer G, Calon F, Nguyen MD.

Mol Neurodegener. 2025 Jun 4;20(1):63. doi: 10.1186/s13024-025-00852-x.

Thioredoxin-interacting protein: an emerging target for Alzheimer's disease

Patil R, Parab SB, Bhatt LK.

Eur J Pharmacol. 2025 Sep 5;1002:177806. doi: 10.1016/j.ejphar.2025.177806. Epub 2025 Jun 4.

Biomaterials in Alzheimer's Disease: An Anti-Neuroinflammatory Perspective

Huang N, Huang W, Wang M, Shi J, Luo Y, Huang J.

Adv Healthc Mater. 2025 Jul;14(19):e2500498. doi: 10.1002/adhm.202500498. Epub 2025 Jun 8.

Fighting Alzheimer's naturally: Peptides as multitarget drug leads

Spinelli R, Sanchís I, Siano A.

Bioorg Med Chem Lett. 2025 Nov 1;127:130305. doi: 10.1016/j.bmcl.2025.130305. Epub 2025 Jun 8.

Amyloid precursor protein carboxy-terminal fragments as catalyzers of endolysosomal dysfunction in Alzheimer's disease

Vrancx C, Annaert W.

Trends Neurosci. 2025 Jul;48(7):538-551. doi: 10.1016/j.tins.2025.05.007. Epub 2025 Jun 12.

A Narrative Review Evaluating Diet and Exercise as Complementary Medicine for the Management of Alzheimer's Disease

Szabo-Reed AN, Key MN.

Nutrients. 2025 May 26;17(11):1804. doi: 10.3390/nu17111804.

Microbiome Engineering for Biotherapeutic in Alzheimer's Disease Through the Gut-Brain Axis: Potentials and Limitations

Renesteen E, Boyajian JL, Islam P, Kassab A, Abosalha A, Makhlouf S, Santos M, Chen H, Shum-Tim C, Prakash S.

Int J Mol Sci. 2025 Jun 2;26(11):5351. doi: 10.3390/ijms26115351.

Regulation of Blood-Brain Barrier Permeability via JNK Signaling Pathway: Mechanisms and Potential Therapeutic Strategies for Ischemic Stroke, Alzheimer's Disease and Brain Tumors

Plotnikov MB, Anishchenko AM, Khlebnikov AI, Schepetkin IA.

Molecules. 2025 May 28;30(11):2353. doi: 10.3390/molecules30112353.

Dual Aβ/tau epitope vaccines: a poorly explored strategy for Alzheimer's disease immunotherapy

León-Arcia K, Pérez-Leal G, Quintero-Álvarez H, Zamora-Loyarte DI, López-Armenteros M, de la Caridad Sánchez-Quesada A, Vázquez-Mojena Y.

Vaccine. 2025 Aug 13;61:127414. doi: 10.1016/j.vaccine.2025.127414. Epub 2025 Jun 21.

Towards Better and More Valid Zebrafish Models of Alzheimer's Disease: A Scientific Tribute to Prof. Mikhail I. Aghajanov

Kotova MM, Stewart AM, Grigoryan A, Shariff S, Mirzaei F, Kantawala B, Dilbaryan K, de Abreu MS, Galstryan DS, Cui J, Yang L, Yenkoyan KB, Kalueff AV.

J Neurochem. 2025 Jun;169(6):e70090. doi: 10.1111/jnc.70090.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias